ECM
ACOR

Element Capital Management’s Acorda Therapeutics ACOR Stock Holding History

Element Capital Management’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-155
Closed -$248K – 806
2019
Q1 		$248K Sell
155
-108
-41% -$195K 0.01% 669
2018
Q4 		$492K Sell
263
-26
-9% -$56.6K 0.01% 366
2018
Q3 		$682K Buy
289
+99
+52% +$306K 0.01% 386
2018
Q2 		$656K Buy
190
+29
+18% +$88.8K 0.02% 315
2018
Q1 		$457K Buy
+161
New +$482K 0.01% 332

Other funds holding ACOR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Element Capital Management's ACOR Position: Q2 2019 in Review

Element Capital Management sold out of Acorda Therapeutics (ACOR) in Q2 2019, closing a stake of 155 shares — an estimated $248K sold.

Element Capital Management first reported a position in ACOR in Q1 2018 and held it in 5 quarters. The position peaked at $682K in Q3 2018. 163 funds tracked by Wall St. Rank hold ACOR as of Q2 2019.

  • Element Capital Management reported no remaining Acorda Therapeutics position as of Q2 2019 after selling out during the quarter.
  • Element Capital Management sold 155 Acorda Therapeutics shares in Q2 2019, an estimated $248K.
  • Element Capital Management first reported a position in Acorda Therapeutics in Q1 2018 and held it in 5 quarters.
  • Element Capital Management's Acorda Therapeutics position peaked at $682K in Q3 2018.
  • 163 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q2 2019.

Based on Element Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.